Skip to main content
Erschienen in: Annals of Surgical Oncology 7/2008

01.07.2008 | Hepatic and Pancreatic Tumors

A New Technique of Biliary Reconstruction After “High Hilar Resection” of Hilar Cholangiocarcinoma with Tumor Extension to Secondary and Tertiary Biliary Radicals

verfasst von: Unal Aydin, MD, Suleyman Yedibela, MD, Pinar Yazici, MD, Bulent Aydinli, MD, Murat Zeytunlu, MD, Murat Kilic, MD, Ahmet Coker, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Radical operation for hilar cholangiocellular carcinoma, including extended hepatic resection, seems to improve prognosis by increasing the surgical curability rate. Nevertheless, high postoperative morbidity and mortality have been reported in patients with obstructive jaundice. We describe the technique of “high hilar resection” and a modification of bilioenteric anastomosis for drainage of the multiple secondary or tertiary biliary radicals.

Methods

Ten patients with advanced hilar cholangiocellular carcinoma underwent a high hilar resection with complete parenchymal preservation, and the biliary drainage was reconstructed by a sheath-to-enteric hepaticojejunostomy. Because of the technical difficulty caused by anastomosis line in the range of the biliary sheath, a modification was performed by dividing the biliary apertures of segments 5 and 4b.

Results

A high hilar resection was successfully performed, and all patients were discharged from the hospital in good condition. No patient died postoperatively. The proximal resection margin was tumor-free in all patients. One patient died after 29 months of peritoneal carcinomatosis. None of the patients developed local recurrence around the hepaticojejunostomy. The remaining nine patients are alive after a mean follow-up of 28.8 months after surgery without any signs of recurrence.

Conclusion

In highly selected patients with advanced hilar cholangiocellular carcinoma, a high hilar resection is technically safe and oncologically justifiable. In combination with our new technique of sheath-to-enteric anastomosis, the patients considerably benefit from the preservation of liver parenchyma with low postoperative morbidity and very short in-hospital stay.
Literatur
1.
Zurück zum Zitat Vautey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 1994; 14:109–14. Vautey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 1994; 14:109–14.
2.
Zurück zum Zitat Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocellular carcinoma: consensus document. Gut 2002; 51:1–9.CrossRef Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocellular carcinoma: consensus document. Gut 2002; 51:1–9.CrossRef
3.
Zurück zum Zitat Bismuth H, Nakache R, Diamont T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215:31–8.PubMedCrossRef Bismuth H, Nakache R, Diamont T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215:31–8.PubMedCrossRef
4.
Zurück zum Zitat Tsao JI, Nimura Y, Kamiya J, et al. Management of hilar cholangiocarcinoma: comparison of an American and Japanese experience. Ann Surg 2000; 232:166–74.PubMedCrossRef Tsao JI, Nimura Y, Kamiya J, et al. Management of hilar cholangiocarcinoma: comparison of an American and Japanese experience. Ann Surg 2000; 232:166–74.PubMedCrossRef
5.
Zurück zum Zitat Kawasaki S, Imamura H, Kobayashi A, et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 2003; 238:84–92.PubMedCrossRef Kawasaki S, Imamura H, Kobayashi A, et al. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 2003; 238:84–92.PubMedCrossRef
6.
Zurück zum Zitat Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, respectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234:507–19.PubMedCrossRef Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, respectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234:507–19.PubMedCrossRef
7.
Zurück zum Zitat Silva MA, Tekin K, Aytekin F, et al. Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK. EJSO 2005; 31:533–9.PubMedCrossRef Silva MA, Tekin K, Aytekin F, et al. Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK. EJSO 2005; 31:533–9.PubMedCrossRef
8.
Zurück zum Zitat Jarnagin WR, Bownw W, Klimstra DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 2005; 241:703–14.PubMedCrossRef Jarnagin WR, Bownw W, Klimstra DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 2005; 241:703–14.PubMedCrossRef
9.
Zurück zum Zitat Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 4th edition. Tokyo: Kanehara. 2000. Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 4th edition. Tokyo: Kanehara. 2000.
10.
Zurück zum Zitat Cameron JL, Pitt HA, Zinner MJ, et al. Management of proximal cholangiocarcinoma by surgical resection and radiotherapy. Am J Surg 1990; 159:91–8.PubMedCrossRef Cameron JL, Pitt HA, Zinner MJ, et al. Management of proximal cholangiocarcinoma by surgical resection and radiotherapy. Am J Surg 1990; 159:91–8.PubMedCrossRef
11.
Zurück zum Zitat Fortner JG, Vitelli CE, Maclean BJ. Proximal extrahepatic bile duct tumors; analysis of a series of 52 consecutive patients treated over a period of 13 years. Arch Surg 1989; 124:1275–9.PubMed Fortner JG, Vitelli CE, Maclean BJ. Proximal extrahepatic bile duct tumors; analysis of a series of 52 consecutive patients treated over a period of 13 years. Arch Surg 1989; 124:1275–9.PubMed
12.
Zurück zum Zitat Sugiura Y, Nakamura S, Iida S, et al. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic junction: A cooperative study of the Keio Bile Duct Cancer Study Group. Surgery 1994; 115:445–51.PubMed Sugiura Y, Nakamura S, Iida S, et al. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic junction: A cooperative study of the Keio Bile Duct Cancer Study Group. Surgery 1994; 115:445–51.PubMed
13.
Zurück zum Zitat Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003; 238:73–83.PubMedCrossRef Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 2003; 238:73–83.PubMedCrossRef
14.
Zurück zum Zitat Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg 1988; 12:39–47.PubMedCrossRef Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg 1988; 12:39–47.PubMedCrossRef
15.
Zurück zum Zitat Miyazaki M, Ito H, Nakagawa K, et al. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg 1999; 189:575–83.PubMedCrossRef Miyazaki M, Ito H, Nakagawa K, et al. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg 1999; 189:575–83.PubMedCrossRef
16.
Zurück zum Zitat Nagino M, Kamiya J, Arai T, et al. “Anatomic” right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilöar cholangiocarcinoma. Ann Surg 2006; 243:28–32.PubMedCrossRef Nagino M, Kamiya J, Arai T, et al. “Anatomic” right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilöar cholangiocarcinoma. Ann Surg 2006; 243:28–32.PubMedCrossRef
17.
Zurück zum Zitat Baton O, Azoulay D, Adam DVR, et al. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg 2007; 204:250–60.PubMedCrossRef Baton O, Azoulay D, Adam DVR, et al. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg 2007; 204:250–60.PubMedCrossRef
18.
Zurück zum Zitat Kosuge T, Yamamoto J, Shimada K, et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230:663–71.PubMedCrossRef Kosuge T, Yamamoto J, Shimada K, et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230:663–71.PubMedCrossRef
19.
Zurück zum Zitat Liu CL, Fan ST, Lo CM, et al. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg 2006; 93:1488–94.PubMedCrossRef Liu CL, Fan ST, Lo CM, et al. Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg 2006; 93:1488–94.PubMedCrossRef
20.
Zurück zum Zitat Seyama Y, Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 2007; 13:1505–15.PubMed Seyama Y, Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 2007; 13:1505–15.PubMed
21.
Zurück zum Zitat Launois B, Jamieson GG. The importance of Glisson’s capsule and its sheath in the intrahepatic approach to resection of the liver. Surg Gynecol Obstet 1992; 174:7–10.PubMed Launois B, Jamieson GG. The importance of Glisson’s capsule and its sheath in the intrahepatic approach to resection of the liver. Surg Gynecol Obstet 1992; 174:7–10.PubMed
22.
Zurück zum Zitat Khan AZ, Makuuchi M. Trends in the surgical management of Klatskin tumours. Br J Surg 2007; 94:393–4.PubMedCrossRef Khan AZ, Makuuchi M. Trends in the surgical management of Klatskin tumours. Br J Surg 2007; 94:393–4.PubMedCrossRef
23.
Zurück zum Zitat Shigeta H, Nagino M, Kamiya J, et al. Bacteremia after hepatectomy: an analysis of single center, 10-year experience with 407 patients. Langenbecks Arch Surg 2002; 387:117–24.PubMedCrossRef Shigeta H, Nagino M, Kamiya J, et al. Bacteremia after hepatectomy: an analysis of single center, 10-year experience with 407 patients. Langenbecks Arch Surg 2002; 387:117–24.PubMedCrossRef
24.
Zurück zum Zitat Yedibela S, Gohl J, Graz V, et al. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol 2005; 12:778–85.PubMedCrossRef Yedibela S, Gohl J, Graz V, et al. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol 2005; 12:778–85.PubMedCrossRef
25.
Zurück zum Zitat Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30:1434–40.PubMedCrossRef Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30:1434–40.PubMedCrossRef
26.
Zurück zum Zitat Poon RT, Fan ST, Lo CM, et al. Improving perioperative expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004; 240:698–708.PubMedCrossRef Poon RT, Fan ST, Lo CM, et al. Improving perioperative expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004; 240:698–708.PubMedCrossRef
27.
Zurück zum Zitat Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer; a single-center experience. Ann Surg 1996; 224:628–38.PubMedCrossRef Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer; a single-center experience. Ann Surg 1996; 224:628–38.PubMedCrossRef
28.
Zurück zum Zitat Neuhaus P, Jonas S, Bechstein WO, et al. Extended resection for hilar cholangiocarcinoma. Ann Surg 1999; 230:808–19.PubMedCrossRef Neuhaus P, Jonas S, Bechstein WO, et al. Extended resection for hilar cholangiocarcinoma. Ann Surg 1999; 230:808–19.PubMedCrossRef
29.
Zurück zum Zitat Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins. Ann Surg 2004; 240:95–101.PubMedCrossRef Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins. Ann Surg 2004; 240:95–101.PubMedCrossRef
30.
Zurück zum Zitat Tomioka M, Iinuma H, Okinaga K. Impaired Kupffer cell function and effect of immunotherapy in obstructive jaundice. J Surg Res 2000; 92:276–82.PubMedCrossRef Tomioka M, Iinuma H, Okinaga K. Impaired Kupffer cell function and effect of immunotherapy in obstructive jaundice. J Surg Res 2000; 92:276–82.PubMedCrossRef
31.
Zurück zum Zitat Clements WD, McCaigue M, Erwin P, et al. Biliary decompression promotes Kupffer cell recovery in obstructive jaundice. Gut 1996; 38:925–31.PubMedCrossRef Clements WD, McCaigue M, Erwin P, et al. Biliary decompression promotes Kupffer cell recovery in obstructive jaundice. Gut 1996; 38:925–31.PubMedCrossRef
32.
Zurück zum Zitat Katz S, Yang R, Rodefeld MJ, et al. Impaired hepatic bacterial clearance is reversed by surgical relief of obstructive jaundice. J Pediatr Surg 1991; 26:401–5.PubMedCrossRef Katz S, Yang R, Rodefeld MJ, et al. Impaired hepatic bacterial clearance is reversed by surgical relief of obstructive jaundice. J Pediatr Surg 1991; 26:401–5.PubMedCrossRef
33.
Zurück zum Zitat Vane DW, Redlich P, Weber T, et al. Impaired immune function in obstructive jaundice. J Surg Res 1988; 45:287–93.PubMedCrossRef Vane DW, Redlich P, Weber T, et al. Impaired immune function in obstructive jaundice. J Surg Res 1988; 45:287–93.PubMedCrossRef
34.
Zurück zum Zitat Dinant S, Gerhards MF, Rauws EAJ, et al. Improved outcome of resection of hilar cholangiocarcinoma (klatskin tumor). Ann Surg 2006; 13:872–80.CrossRef Dinant S, Gerhards MF, Rauws EAJ, et al. Improved outcome of resection of hilar cholangiocarcinoma (klatskin tumor). Ann Surg 2006; 13:872–80.CrossRef
35.
Zurück zum Zitat Kasai M., Kimura S, Asakura Y, et al. Surgical treatment of biliary atresia. J Pediatr Surg 1968; 3:665–75.CrossRef Kasai M., Kimura S, Asakura Y, et al. Surgical treatment of biliary atresia. J Pediatr Surg 1968; 3:665–75.CrossRef
36.
Zurück zum Zitat Icoz G, Kilic M, Zeytunlu M, et al. Biliary reconstructions and complications encountered in 50 consecutive right-lobe living donor liver transplantations. Liver Transpl 2003; 9:575–80.PubMedCrossRef Icoz G, Kilic M, Zeytunlu M, et al. Biliary reconstructions and complications encountered in 50 consecutive right-lobe living donor liver transplantations. Liver Transpl 2003; 9:575–80.PubMedCrossRef
Metadaten
Titel
A New Technique of Biliary Reconstruction After “High Hilar Resection” of Hilar Cholangiocarcinoma with Tumor Extension to Secondary and Tertiary Biliary Radicals
verfasst von
Unal Aydin, MD
Suleyman Yedibela, MD
Pinar Yazici, MD
Bulent Aydinli, MD
Murat Zeytunlu, MD
Murat Kilic, MD
Ahmet Coker, MD
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 7/2008
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-9926-x

Weitere Artikel der Ausgabe 7/2008

Annals of Surgical Oncology 7/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.